Analysts explain why Hims&Hers stock is crashing today

Investing.comFeb 21, 2025 5:10 PM

View all comments（0）



On Friday, shares of Hims&Hers Health Inc (NYSE:HIMS) dropped over 20% following an FDA announcement that the supply shortage of Novo Nordisk (NYSE:NVO)'s weight loss and diabetes drugs was ending. Due to this, the sale price and availability of Ozempic and Wegovy are impacted, which disallows Hims and Hers from selling exact replicas of the semaglutide drugs at a lower price.

In response to the news, BofA analyst Allen Lutz maintained an Underperform rating and a price target of $21.00, citing the news as a "clear negative" for Hims&Hers' GLP-1 opportunity.

The analyst stated, "Today’s news is a clear negative for HIMS and indicates the duration of the semaglutide opportunity is likely limited to 2025, creating a potentially material headwind to growth in 2H. Based on the FDA’s recent policies on the resolution of the tirzepatide shortage, we expect state-licensed pharmacies under 503A to have 60 calendar days and 503B facilities to have 90 calendar days from today’s determination to stop manufacturing compounded semaglutide."

Lutz iterated that semaglutide drugs are expected to account for nearly half of gross sales for the company in Q2. He also cited that the company's core product line has decelerated to represent only 30% gross sales as of January.

Leerink Partners analyst Michael Cherry answered the news with similar concern, stating, "For HIMS (MP) and the broader GLP-1 compounding space, this development starts the clock on having unfettered market access to the patented drug."

The analyst appeared skeptical of the stock's immediate future, adding, "From here, we do see potential for a reset in the stock after it had been clearly driven up by excitement over the broader weight loss opportunity." Cherry reiterated a price target of $24.00 and a Market Perform rating, and advocated for understanding of Hims and Hers' potential legal pathway.

It should be noted that Hims and Hers stock had jumped 43% in the week prior to the announcement, which has been attributed to the acquisition of Tybre Labs and a controversial Super Bowl ad. Investors will be following closely, as the company is set to report earnings on February 24, 2025.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

Commenting Guidelines

Recommended Articles

Tesla Stock Forecast: TSLA Triangle Breakout Targets $411.90 as Cybercabs Overtake Model Ys

TradingKey - Tesla stock forecast: TSLA breaks out of a triangle above $388.85 as Cybercabs overtake Model Ys in Texas, with $411.90 the next hurdle on the 4-hour chart.

SK Hynix Surges Over 4% as Q3 Results Hit Record High, Returning $75 Billion to Shareholders

SK Hynix reported a record-breaking Q3 operating profit while announcing a massive 100 trillion won (approximately $75 billion) shareholder return plan, sending its stock price surging 4%.

KOSPI Tops 5,800, Kioxia Jumps Over 4% as SK Hynix Revenue and Profit Hit Record Highs

The KOSPI surged over 3%, Kioxia jumped 4%, Samsung and SoftBank joined the rally, and SK Hynix unveiled a massive 100 trillion KRW in shareholder returns.

US Stocks Close: Nasdaq Rises Over 1%, Philadelphia Semiconductor Index Gains Over 3%; Chip Stocks Extend Rally, CoreWeave Gains Nearly 8%

On Tuesday, October 27, Eastern Time, U.S. stocks moved higher, with chip stocks extending their rally to drive the Nasdaq to lead the gains. Amid falling oil prices, investors continued to assess a heavy slate of corporate earnings reports while focusing on the Federal Reserve's interest rate meeting. At the close, the Dow Jones Industrial Average rose 0.03% to 52,377.57 points; the Nasdaq Composite Index gained 1.18% to 26,477.81 points; and the S&P 500 Index advanced 0.60% to 7,722.60 points.

Amazon Q3 Earnings Preview: AWS Growth Expected to Rise to 41%, Wall Street Top Price Target $400

TradingKey - Amazon (AMZN) will release its third-quarter 2026 financial results after the U.S. market close on October 29, Eastern Time, and hold an earnings conference call at 17:00 on the same day.

Featured Tools